AEON Biopharma Inc.
AEON | AMEX
$0.48
-$0.02 (-4.52%)
Jul 10, 2026, 3:58 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | 2.52M |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | 2.52M |
Operating Income | -12.8M | 72.99M | -348.09M | -48.43M | -65.85M | -16.39M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -39.22M | 42.01M | -384.63M | -52.56M | -55.64M | -32.91M |
Net Income | -39.22M | 42.01M | -384.63M | -52.56M | -55.64M | -32.91M |
Selling & General & Admin | 12.21M | 13.64M | 19.79M | 13.68M | 11.15M | 11.59M |
Research & Development | 4.09M | 14.18M | 33.05M | 34.75M | 25.73M | 7.32M |
Other Expenses | -3.5M | -100.81M | 295.25M | n/a | 28.97M | n/a |
Operating Expenses | 12.8M | -72.99M | 348.09M | 48.43M | 65.85M | 18.91M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | 15K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 12.8M | -72.99M | 348.09M | 48.43M | 65.85M | 18.91M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 9.92M | 575K | 77.07M | 1.93M | 1.75M | 60K |
Shares Outstanding (Diluted) | 9.92M | 575.95K | 77.07M | 1.93M | 1.75M | 91.62K |
EPS (Basic) | -3.95 | 77.74 | -4.99 | -27.25 | -31.73 | -547.60 |
EPS (Diluted) | -3.95 | 72.93 | -4.99 | -27.25 | -31.73 | -547.60 |
EBITDA | -16.22M | -27.73M | -52.74M | -52.49M | -36.88M | -15.51M |
EBIT | -16.3M | -27.82M | -52.84M | -52.56M | -36.88M | -16.39M |
Depreciation & Amortization | 78K | 97K | 99K | 68K | 3K | 875K |
Add to Watchlist
Select watchlists to add or remove AEON